The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
Mayo Clinic in Rochester
Rochester, Minnesota, United States
RECRUITINGPain Scores
Measured using a visual analog scale 0=no pain and 10=worst possible
Time frame: 7-10 days following the last administration of study treatment
Change in oral pain medication
Total oral pain medication usage self-reported in pain medication diary
Time frame: 7-10 days following the last administration of study treatment
Adverse Reactions
Total number of adverse reactions reported to the study agent
Time frame: 7-10 days following the last administration of study treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.